Sec. 1.5. As used in this chapter, “therapeutic alternative” means a drug product that:

(1) has a different chemical structure from;

(2) is in the same pharmacological or therapeutic class as; and

(3) usually can be expected to have similar therapeutic effects and adverse reaction profiles when administered to patients in therapeutically equivalent doses as;

another drug.

As added by P.L.207-2021, SEC.42.